ATA282386A - Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren - Google Patents

Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren

Info

Publication number
ATA282386A
ATA282386A AT0282386A AT282386A ATA282386A AT A282386 A ATA282386 A AT A282386A AT 0282386 A AT0282386 A AT 0282386A AT 282386 A AT282386 A AT 282386A AT A282386 A ATA282386 A AT A282386A
Authority
AT
Austria
Prior art keywords
dna fragments
yeast
heme
segment
expressing genes
Prior art date
Application number
AT0282386A
Other languages
English (en)
Other versions
AT396249B (de
Inventor
Kjeld Adrian Marcker
Jensen Erik Ostergard
Original Assignee
Danske Sukkerfab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danske Sukkerfab filed Critical Danske Sukkerfab
Publication of ATA282386A publication Critical patent/ATA282386A/de
Application granted granted Critical
Publication of AT396249B publication Critical patent/AT396249B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT0282386A 1985-10-24 1986-10-23 Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren AT396249B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK488985A DK162900C (da) 1985-10-24 1985-10-24 Fremgangsmaade til ekspression af gener i gaer samt dna-fragment, rekombineret dna-segment og plasmider, hvor disse indgaar til brug ved udoevelse af fremgangsmaaden

Publications (2)

Publication Number Publication Date
ATA282386A true ATA282386A (de) 1992-11-15
AT396249B AT396249B (de) 1993-07-26

Family

ID=8137569

Family Applications (2)

Application Number Title Priority Date Filing Date
AT86114704T ATE90386T1 (de) 1985-10-24 1986-10-23 Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.
AT0282386A AT396249B (de) 1985-10-24 1986-10-23 Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT86114704T ATE90386T1 (de) 1985-10-24 1986-10-23 Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.

Country Status (19)

Country Link
US (1) US4849348A (de)
EP (1) EP0220679B1 (de)
JP (1) JPS62181787A (de)
AT (2) ATE90386T1 (de)
AU (1) AU593296B2 (de)
BR (1) BR8605221A (de)
CA (1) CA1333162C (de)
DE (2) DE3688549T2 (de)
DK (1) DK162900C (de)
ES (1) ES2054608T3 (de)
FI (1) FI91083C (de)
FR (1) FR2598432B1 (de)
GB (1) GB2183656B (de)
IE (1) IE59114B1 (de)
NL (1) NL8602657A (de)
NO (1) NO175103C (de)
NZ (1) NZ217948A (de)
PT (1) PT83616B (de)
SE (1) SE8604517L (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162399C (da) * 1986-01-28 1992-03-23 Danisco Fremgangsmaade til ekspression af gener i baelgplanteceller, dna-fragment, rekombineret dna-fragment samt plasmid til brug ved udoevelsen af fremgangsmaaden
WO1994027428A1 (en) * 1993-05-24 1994-12-08 University Of Massachusetts Medical Center Post-transcriptional gene regulation by trace minerals
US5824511A (en) * 1995-08-01 1998-10-20 University Technology Corporation Method for enhancing the production of hemoproteins
US6575703B2 (en) 2001-07-20 2003-06-10 General Electric Company Turbine disk side plate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341116C (en) * 1983-02-22 2000-10-17 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein

Also Published As

Publication number Publication date
NO864250D0 (no) 1986-10-23
DK162900C (da) 1992-05-11
DE3688549T2 (de) 1993-09-23
FI91083B (fi) 1994-01-31
GB8625180D0 (en) 1986-11-26
AU6433886A (en) 1987-05-07
EP0220679A3 (en) 1988-09-21
SE8604517L (sv) 1987-04-25
US4849348A (en) 1989-07-18
CA1333162C (en) 1994-11-22
NO175103C (no) 1994-08-31
FI91083C (fi) 1994-05-10
DE3688549D1 (de) 1993-07-15
SE8604517D0 (sv) 1986-10-23
FI864301A0 (fi) 1986-10-23
PT83616B (pt) 1988-10-14
IE59114B1 (en) 1994-01-12
ES2054608T3 (es) 1994-08-16
EP0220679A2 (de) 1987-05-06
FR2598432A1 (fr) 1987-11-13
DK488985D0 (da) 1985-10-24
GB2183656A (en) 1987-06-10
NL8602657A (nl) 1987-05-18
GB2183656B (en) 1990-01-31
IE862793L (en) 1987-04-24
BR8605221A (pt) 1987-07-28
AU593296B2 (en) 1990-02-08
NO864250L (no) 1987-04-27
FI864301A (fi) 1987-04-25
NO175103B (no) 1994-05-24
EP0220679B1 (de) 1993-06-09
ATE90386T1 (de) 1993-06-15
NZ217948A (en) 1989-01-06
AT396249B (de) 1993-07-26
DK162900B (da) 1991-12-23
PT83616A (en) 1986-11-01
DE3636117A1 (de) 1987-07-16
DK488985A (da) 1987-04-25
JPS62181787A (ja) 1987-08-10
FR2598432B1 (fr) 1989-09-15

Similar Documents

Publication Publication Date Title
DK97784A (da) Dna-segment
DE3578435D1 (de) Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
ES2056799T3 (es) Moleculas de adn codante para las regiones de control fmdh y gen estructural para una proteina que tiene una actividad de fmdh y su uso.
DE69839584D1 (de) Verfahren zur erhöhung der leistungsfähigkeit der rekombinanten aav produktion
GR3024002T3 (en) Recombinant DNA method and host cells
DE3688900D1 (de) Expression von protein c.
EP0111814A3 (de) Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
ATA282386A (de) Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren
ATE399862T1 (de) Menschliche nukleinsäuresequenz aus prostatatumorgewebe
KR940002352A (ko) 디(d)-아미노산 옥시다제 생산성 형질전환체
ATA435083A (de) Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen
Arthur et al. High level expression of interleukin-1β in a recombinant Escherichia coli strain for use in a controlled bioreactor
ATE111527T1 (de) Herstellung und verwendung einer dna zur erhöhung der ausbeute bei der expression von rekombinanten genen.
DE58909205D1 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee